These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 20673026
1. Opposite effects of transforming growth factor-β1 and vascular endothelial growth factor on the degeneration of aortic valvular interstitial cell are modified by the extracellular matrix protein fibronectin: implications for heart valve engineering. Gwanmesia P, Ziegler H, Eurich R, Barth M, Kamiya H, Karck M, Lichtenberg A, Akhyari P. Tissue Eng Part A; 2010 Dec; 16(12):3737-46. PubMed ID: 20673026 [Abstract] [Full Text] [Related]
2. Connective tissue growth factor knockdown attenuated matrix protein production and vascular endothelial growth factor expression induced by transforming growth factor-beta1 in cultured human peritoneal mesothelial cells. Xiao L, Sun L, Liu FY, Peng YM, Duan SB. Ther Apher Dial; 2010 Feb; 14(1):27-34. PubMed ID: 20438517 [Abstract] [Full Text] [Related]
3. Vascular smooth muscle cells as a valvular interstitial cell surrogate in heart valve tissue engineering. Appleton AJ, Appleton CT, Boughner DR, Rogers KA. Tissue Eng Part A; 2009 Dec; 15(12):3889-97. PubMed ID: 19563261 [Abstract] [Full Text] [Related]
4. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events. Clark-Greuel JN, Connolly JM, Sorichillo E, Narula NR, Rapoport HS, Mohler ER, Gorman JH, Gorman RC, Levy RJ. Ann Thorac Surg; 2007 Mar; 83(3):946-53. PubMed ID: 17307438 [Abstract] [Full Text] [Related]
5. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Yip CY, Chen JH, Zhao R, Simmons CA. Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):936-42. PubMed ID: 19304575 [Abstract] [Full Text] [Related]
6. Role of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome. Mauro M, Kim J, Costello C, Laurence J. Am J Hematol; 2001 Jan; 66(1):12-22. PubMed ID: 11426486 [Abstract] [Full Text] [Related]
7. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model. Jenke A, Kistner J, Saradar S, Chekhoeva A, Yazdanyar M, Bergmann AK, Rötepohl MV, Lichtenberg A, Akhyari P. Am J Physiol Heart Circ Physiol; 2020 Nov 01; 319(5):H1123-H1141. PubMed ID: 32986963 [Abstract] [Full Text] [Related]
9. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells. Peng Y, Liu H, Liu F, Liu Y, Li J, Chen X. Nephrology (Carlton); 2006 Dec 05; 11(6):516-23. PubMed ID: 17199790 [Abstract] [Full Text] [Related]
10. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA. Circ Res; 2004 Aug 06; 95(3):253-60. PubMed ID: 15217906 [Abstract] [Full Text] [Related]
11. Designing scaffolds for valvular interstitial cells: cell adhesion and function on naturally derived materials. Masters KS, Shah DN, Walker G, Leinwand LA, Anseth KS. J Biomed Mater Res A; 2004 Oct 01; 71(1):172-80. PubMed ID: 15368267 [Abstract] [Full Text] [Related]
12. Activation of valvular interstitial cells is mediated by transforming growth factor-beta1 interactions with matrix molecules. Cushing MC, Liao JT, Anseth KS. Matrix Biol; 2005 Sep 01; 24(6):428-37. PubMed ID: 16055320 [Abstract] [Full Text] [Related]
14. Interleukin-7 modulates extracellular matrix production and TGF-beta signaling in cultured human subconjunctival fibroblasts. Yamanaka O, Saika S, Ikeda K, Miyazaki K, Ohnishi Y, Ooshima A. Curr Eye Res; 2006 Jun 01; 31(6):491-9. PubMed ID: 16769608 [Abstract] [Full Text] [Related]
15. [Application of transforming growth factor-beta(1) on construction of tissue engineering heart valves: experimental in vitro]. Dong NG, Qiu YM, Shi JW. Zhonghua Yi Xue Za Zhi; 2007 Jun 19; 87(23):1622-6. PubMed ID: 17803853 [Abstract] [Full Text] [Related]
16. VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration. Li D, Zhang C, Song F, Lubenec I, Tian Y, Song QH. Microvasc Res; 2009 Mar 19; 77(2):134-42. PubMed ID: 18948122 [Abstract] [Full Text] [Related]
17. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Fujiwara M, Muragaki Y, Ooshima A. Arch Dermatol Res; 2005 Oct 19; 297(4):161-9. PubMed ID: 16184401 [Abstract] [Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts. Zhang GY, Cheng T, Zheng MH, Yi CG, Pan H, Li ZJ, Chen XL, Yu Q, Jiang LF, Zhou FY, Li XY, Yang JQ, Chu TG, Gao WY. J Plast Reconstr Aesthet Surg; 2010 Jul 19; 63(7):1209-16. PubMed ID: 19617014 [Abstract] [Full Text] [Related]
19. TGF-beta1 up-regulates paxillin protein expression in malignant astrocytoma cells: requirement for a fibronectin substrate. Han X, Stewart JE, Bellis SL, Benveniste EN, Ding Q, Tachibana K, Grammer JR, Gladson CL. Oncogene; 2001 Nov 29; 20(55):7976-86. PubMed ID: 11753680 [Abstract] [Full Text] [Related]
20. Immunohistochemical expression of growth factors in subacute thyroiditis and their effects on thyroid folliculogenesis and angiogenesis in collagen gel matrix culture. Toda S, Nishimura T, Yamada S, Koike N, Yonemitsu N, Watanabe K, Matsumura S, Gärtner R, Sugihara H. J Pathol; 1999 Aug 29; 188(4):415-22. PubMed ID: 10440753 [Abstract] [Full Text] [Related] Page: [Next] [New Search]